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There is a large amount of evidence available about the relative merits of unicompartmental 
and total knee arthroplasty (UKA and TKA). Based on the same evidence, different people 
draw different conclusions and as a result, there is great variability in the usage of UKA.
 The revision rate of UKA is much higher than TKA and so some surgeons conclude that 
UKA should not be performed. Other surgeons believe that the main reason for the high 
revision rate is that UKA is easy to revise and, therefore, the threshold for revision is low. 
They also believe that UKA has many advantages over TKA such as a faster recovery, lower 
morbidity and mortality and better function. They therefore conclude that UKA should be 
undertaken whenever appropriate. 
The solution to this argument is to minimise the revision rate of UKA, thereby addressing 
the main disadvantage of UKA. The evidence suggests that this will be achieved if surgeons 
use UKA for at least 20% of their knee arthroplasties and use implants that are appropriate 
for these broad indications. 
Cite this article: Bone Joint J 2015;97-B(10 Suppl A):3–8.
The burden of knee osteoarthritis (OA) is huge.
Epidemiological studies estimate that the life-
time risk of developing symptomatic arthritis of
the knee is 50%, with 50% of cases being diag-
nosed by the age of 55 years.1 International
trends suggest that this number will continue to
rise substantially, largely because of the ageing
population and an increased prevalence of risk
factors, particularly obesity.2 The demand is
projected to grow by more than 600% by 2030.
In 2013, almost 100 000 primary knee arthro-
plasties were performed within the United King-
dom, an increase of 25% on 2010.3
It is important that patients are offered a treat-
ment which is safe and effective. For a treatment
to be safe, it should have minimum risk of major
complications including risk of dying, myocar-
dial infarction, thromboembolism and infection.
For a treatment to be effective, it should relieve
the patient of their symptoms, allowing them to
return to a normal life sooner rather than later
and to engage in activities of daily living includ-
ing recreational and social events. In addition,
the risk of needing further intervention should be
minimal and when the intervention is needed, it
should be relatively straightforward, with a pre-
dictable outcome.
Two treatment options to treat end-stage
knee OA are unicompartmental knee arthro-
plasty (UKA) and total knee arthroplasty
(TKA). UKA replaces only the arthritic part of
the joint, while TKA replaces the entire knee
joint. While studies demonstrate that up to a
half of patients may be suitable for UKA, there
is a huge variability in the usage of UKA
between surgeons, ranging from 0% to 50%
(mean 8%) of all primary knee arthroplasties.4,5
One of the main reasons for this wide variation
in practice is that surgeons interpret the evi-
dence about the relative benefits and risks of
UKA and TKA in different ways.
In this article, which focuses on National
Registry data, we will put forward the argu-
ments used by the proponents of TKA and
UKA and explain why this leads to very polar-
ised views. We then highlight the differences
and provide solutions.
TKA is better – the glass is half empty
The principal reason National Joint Registries
were established was to identify poorly per-
forming implants. It is felt that Registries are
ideally suited for this as the numbers of joint
arthroplasties studied are very large, thus, dif-
ferences will be detected early and are likely to
be statistically significant. Furthermore, as the
data are collected from all surgeons, conclu-
sions based on Registry data should be appli-
cable across a country, which is not necessarily
the case for cohort or randomised studies. This
type of data should, therefore, be an ideal basis
for National Guidelines. In every National
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Registry the revision rate of UKA is much higher than TKA.
For example, in the largest National Registry in the world,
the National Joint Registry (NJR) for England, Wales and
Northern Ireland, the revision rate is 3.2 times higher for
UKA than TKA (Fig. 1).6 Furthermore, in National Regis-
try studies based on patient reported outcome scores
(PROMS), UKA has no advantage in terms of satisfaction
or functional improvement.7,8 With such a large difference
in revision rate and no functional advantage, surgeons
should stop using UKA. This would save patients from the
increased risk of further surgery and save large sums of
money for the health service.9
National Registries were also established to identify sur-
geons with high revision rates and to provide them with the
necessary information to help them improve their results. In
both Sweden and Australia in recent years there has been a
steady decrease in the use of UKA.10,11 This may, in part, be
because the Registries have been informing the surgeons of
the high revision rate with UKA and encouraging them to
stop using it. A very effective outlier system has been estab-
lished by the NJR. Surgeon’s revision rates for knee arthro-
plasties are plotted on funnel plots and if the revision rate is
more than three standard deviations from the mean they
are identified as outliers (Fig. 2). They are then contacted,
sent the relevant information and asked to check it, and
encouraged to rectify the situation. Surgeons who under-
take large numbers of UKA are more likely to be outliers
than those who do not. The reason for this is that UKA has
a much higher revision rate than TKA. Therefore when
data from all knee arthroplasties are combined, surgeons
that do UKA as well as TKA will have a higher revision rate
than those who just do TKA. As a result, many outliers
are surgeons who do UKA and the simplest way they can
stop being outliers is to undertake fewer UKAs, or to stop
completely.
During their training, surgeons learn that there are many
contraindications to UKA.12 As surgeons are worried about
the revision rate of UKA they will tend to use narrow indi-
cations and just operate on patients they would consider to
be ideal. The biggest concern about UKA is disease progres-
sion in the retained compartments. Many surgeons, there-
fore, undertake UKA only on patients with medial damage
who have pristine lateral and patellofemoral joints. These
patients tend to have early arthritis. Knee arthroplasty,
both UKA and TKA, is unreliable in early arthritis, with
more patients having poor results than in end-stage arthri-
tis.13,14 Therefore a vicious circle may develop in which sur-
geons, who are anxious about revision of UKA, have
narrow indications and do small numbers, and then have a
high revision rate. They will further narrow their indica-
tions and may eventually stop UKA completely. The high
revision rate will then contribute to the high revision rate in
the Registries. 
UKA is better – the glass is half full
Although there are differences between Registries, they
tend to collect data when any joint arthroplasty component
is implanted, and generally a revision is considered to have
occurred the second time a component is inserted into a
particular joint. When a revision occurs, the implant is con-
sidered to have failed and a survival analysis is conducted
on this basis. If an implant has not been revised, it is con-
sidered to be a success even if it is painful and has poor
function. Revision is a hard end point, but may be biased
because revisions are of different magnitude and may be
undertaken at different thresholds. Revisions of UKA tend
to be of a lesser magnitude than revision of TKA. UKA revi-
sions are commonly simple conversions to a primary TKA,
addition of a lateral UKA (for disease progression after
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Fig. 1
Graph showing the Kaplan-Meier survival of unicompartmental and
total knee arthroplasty (UKA and TKA) based on data from the National
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Fig. 2
Funnel plot taken from the National Joint Registry for all knee arthro-
plasties combined for an example surgeon who is an outlier. His knee
arthroplasty practice includes a large proportion of unicompartmental
knee arthroplasties.
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wear or mobile bearing dislocation), whereas TKA revi-
sions tend to be complex and involve stems, wedges and
stabilised components. Furthermore, the major problems
which can occur after TKA such as amputation, knee fusion
or death resulting from surgery may not be considered to be
revisions, and thus the operation is considered to be a suc-
cess.15 Therefore, a fairer endpoint with which to compare
UKA and TKA is any re-operation.
As a revision of a UKA is generally much easier than a
revision of a TKA, it is likely that the threshold for revision
of UKA is lower than that of TKA, so the higher revision
rate would not necessarily suggest that UKA have a worse
outcome than TKA. There is good evidence to suggest that
this is indeed the case. The New Zealand Joint Registry
(NZJR), as well as collecting data about revision, collects
Oxford knee scores16 (OKS) at six months after the opera-
tion and categorises these into poor, fair, good and excel-
lent.17,18 Data from the NZJR demonstrate that UKAs have
more excellent and fewer poor results than TKAs, so the
higher revision rate is not because UKAs have more poor
results (Fig. 3).15 The NZJR also compares the six-month
OKS with the subsequent revision rate. The graph in Figure 4,
based on NZJR data, demonstrates that whatever the out-
come score, the revision rate of UKA is about five times
higher than that of TKA.15 This suggests that factors inde-
pendent of outcome score increase the revision rate by five
times. The most important factor is likely to be a different
threshold for revision. The most striking difference in
revision rate occurs in patients who have a worse score
post-operatively than pre-operatively (OKS less than about
20). These patients have a 10% chance of being revised if
they have had a TKA and a 60% chance of being revised if
they have had a UKA. Most surgeons would agree that it is
an advantage of UKA over TKA that it is relatively straight-
forward to revise if there is a problem. The consequence of
it being easy to revise is that the threshold for revision is
lower. As a result, the revision rate is higher, even though
the chance of getting a poor result is lower. The higher revi-
sion rate of UKA should thus not be considered to be a
problem because it is a manifestation of an advantage.
When Joint Registries compare UKA and TKA they tend
to use raw, unmatched data.19 As UKA tends to be
implanted in younger and more active patients than TKA,
such comparisons are invalid. The only fair way to compare
UKA and TKA is to match patients who have had UKA
with those who have had TKA. A matched comparison of
UKA and TKA based on NJR data and other large datasets
has been undertaken.4 In total, 100 000 knee arthroplasties
were matched on a 1:3 basis using propensity score analysis
of 20 variables. UKA were found to have many advantages
- the length of stay was a mean 1.4 days shorter, the re-
admission rate within the first year was two thirds of that
found in TKA, intra-operative complications and transfu-
sions were a quarter. Major medical complications, such
as thromboembolism, infection, stroke and myocardial


















Graph showing the percentage of unicompartmental and total knee
arthroplasties (UKA and TKA) having poor, fair, good and excellent out-






















Graph showing the two-year revision rates for unicompartmental and
total knee arthroplasty (UKA and TKA) having different Oxford knee
score (OKS) categories at six months post-surgery, based on data from
the New Zealand Joint Registry.15
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frequently. The mortality following UKA was also signifi-
cantly lower (hazard ratio at 30 days was 0.23, at 90 days
it was 0.46 and at eight years it was 0.87). The survival
curves (based on death) progressively separated for about
four years and thereafter remained parallel, suggesting that
effect of surgery on the death rate lasted for four years. The
main disadvantage of UKA was that it had a higher revision
rate. At eight years the revision rate was 2.1 times higher
and the re-operation rate was 1.4 times higher.4
In a separate matched study of about 15 000 patients, the
PROMS of UKA and TKA were compared.20 The pre-
operative OKS of both UKA and TKA were the same (mean
scores of 22). At six months the OKS was significantly bet-
ter with UKA (mean 38) than TKA (mean 36). Although
the difference in mean was small and may not be clinically
important, many more patients achieved an excellent OKS
(OKS > 41) with UKA (odds ratio (OR) 1.6). The overall
EuroQuol21 score was also significantly better with UKA:
the four subscales relating to mobility, pain, function and
self care were significantly better but, in the subscale of
anxiety, there was no significant difference. The level of
patient satisfaction was also assessed and significantly
more (OR 1.3) patients achieved excellent satisfaction with
UKA. There are no other matched comparisons of UKA
and TKA based on PROMS from National Registers. An
unmatched comparison from the NZJR showed a signifi-
cantly better mean OKS with UKA (39) than TKA (37).15,22
Similarly, in an unmatched comparison based on NJR data,
there was a significantly better mean OKS with UKA (35.5)
than TKA (34.0). However, in this study (which had a rel-
atively small number of UKAs) there was no significant dif-
ference in the improvement in mean OKS between UKA
and TKA when adjusted for other factors.7
The conclusion from these analyses is that UKA are bet-
ter than TKA and, therefore, that the numbers undertaken
should increase. Patients who have UKA recover quicker,
have lower mortality and morbidity and have better
function. UKA is, however, associated with a higher revi-
sion rate, but this is primarily because UKAs are easy to
revise, therefore, the threshold for revision is lower. Fur-
thermore, if 100 patients had a UKA instead of a TKA then
over an eight-year period there would be one fewer deaths
and three more revision operations.4
The solution – fill the glass!
It is clear that despite the evidence being the same, different
individuals draw different conclusions. An insight into
what is going on can be obtained from an ad hoc survey
which was undertaken.23 When knee surgeons were asked
whether they performed UKA or not, the majority
answered no. However, when asked if they had medial
compartment arthritis would they have UKA, the majority
answered yes. Clearly surgeons appreciate that UKA gives
better outcomes, but are perhaps too concerned about the
risk of revision to do UKA themselves. Although there is
debate about how much the threshold for revision influ-
ences the relative revision rate of UKA and TKA, it cer-
tainly does influence it to some extent. Therefore, the
revision rate should not be used in isolation to compare
UKA and TKA. The Registers should make this clear, as the
Danish Joint Register has already done.24
If revision is not a reliable way to compare UKA and
TKA, then the outlier system in the NJR should change.
The surgeon whose funnel plot is shown in Figure 2 is an
outlier for knee arthroplasties (all combined). His funnel
plots for both UKA (Fig. 5a) and TKA (Fig. 5b) show that
he has an average revision rate for both UKA and TKA, and
so he should not be considered to be an outlier. Thus, when
identifying outliers, either UKA and TKA should not be
combined or the method used to combine them should be
altered by adjusting for the relative revision rates of UKA
and TKA. There are a number of ways that this can be done
from a statistical point of view, for example, by using the
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Fig. 5a
Funnel plots for a) total knee arthroplasty and b) unicompartmental knee arthroplasty for a surgeon who is an outlier for all knee arthroplasties com-
bined (Fig. 2).
Fig. 5b
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was produced, based on WMIR, for all knee arthroplasties
combined for this example surgeon, it would correctly demon-
strate that he has an average revision rate and is not an outlier.
The revision rate for UKA is much higher in National
Registries than in many cohort studies.14 The main reason
for this is surgical experience. In the National Registers,
most surgeons are undertaking very small numbers
whereas, in published series, surgeons tend to undertake
large numbers. The data from the NJR show that the most
common number of UKAs implanted per surgeon per year
is one and the second most common number is two;25 the
average number is five. When the number of UKAs per-
formed per surgeon per year were compared with the revi-
sion rate, it was found that the surgeons doing small
numbers had a very high revision rate.25 The surgeons
doing one or two UKAs per year had a 4% failure rate per
year which would equate to about a 60% survival at ten
years. The revision rate dramatically decreases with
increasing numbers. Surgeons undertaking about ten UKAs
per year have a revision rate of 2% per year, whereas sur-
geons undertaking about 30 per year have a revision rate of
1% per year. In the matched comparison, it was found that
surgeons doing more than 30 per year had a re-operation/
revision rate that was not statistically different from the re-
operation/revision rate of TKA.25
As surgeons cannot easily increase the size of their knee
arthroplasty practice, the only way they can increase the
number of UKAs they implant is by increasing the propor-
tion of knee arthroplasties that are UKAs. In order to do
this, they may have to broaden their indications for UKA. If
they use broad indications they have to ensure that the
implant they use is appropriate for the indications. It is
likely that the indications and contraindications may be
different for different devices and, in particular, they may
be different for mobile and fixed bearing implants. The
indications and contraindications for fixed bearing devices
were summarised by Kozinn and Scott in 1989,12 but they
did not have a good evidence base. The evidence that exists
suggests that damage to the patellofemoral joint, obesity,
youth and high activity levels should be considered to be
contraindications.12,26 In contrast, there is good evidence
that with the Oxford UKA (Zimmer Biomet, Bridgend,
United Kingdom) provided the main indication antero-
medial osteoarthritis (AMOA) is satisfied, these and the
other contraindications proposed by Kozinn and Scott12 do
not apply.27 AMOA is clearly defined and requires bone-
on-bone medial OA, full thickness cartilage laterally, a
functionally intact anterior cruciate ligament and a correct-
able intra-articular deformity. These criteria are satisfied in
about 50% of knees requiring arthroplasty, and so the
Oxford UKA can be used safely in about 50% of knee
arthroplasties. It is not clear in what proportion of knees
fixed bearing devices can safely be used. Although some
have suggested it is 5% to 10%, it is likely that the figure is
higher than this.28
Figure 6 shows the relationship, for the Oxford UKA,
between the revision rate and the percentage of a surgeon’s
knee arthroplasties that are UKA.29 The shape of the graph is
not what would be expected. The revision rate for surgeons
with a 10% usage or less is very high. As the usage increases,
the revision rate dramatically decreases until 20% usage.
Thereafter, with increasing usage, there is a slow but steady
decrease in the revision rate, which is at its lowest when
usage is at around 50%. With optimal usage (40% to 60%)
it was found in the matched study that the re-operation/revi-
sion rate of UKA was not statistically different from that of
TKA.29 Above 60%, although the data are unreliable
because the numbers are small, the revision rate increases,
suggesting that very high usage rates should be avoided.
With fixed bearing UKA the situation is similar with decreas-
ing revisions rates as usage increases to 20%. However,
above 20% the revision rate does not drop further. 
In conclusion, if surgeons want to undertake UKA they
should aim for a usage of 20% or more. If they do this they
should ensure that the implant they use is appropriate for
these broad indications. With usage rates of 20% or more,
patients should have all the benefits of UKA without the
high revision rate. 
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Fig. 6
Graph showing the relationship for the Oxford unicompartmental knee
arthroplasty (UKA) between revision rate (revisions per 100 component
years) and usage of UKA (the percentage of a surgeon’s knee arthro-
plasties that are UKA), based on data from the National Joint Registry.
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